Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Astellas Pharma Announces Approval of VYLOYTM for Advanced Gastric Cancer
Monday, January 06, 2025Astellas Pharma has announced that Chinas National Medical Products Administration NMPA has approved VYLOYTM zolbetuximab for firstline treatment of patients with locally advanced unresectable or metastatic HERnegative gastric or gastroesophageal jun...
Abu Dhabi Stem Cells Centre Develops Clinical-Grade iPSCs with Exclusive Virus-Free
Saturday, January 04, 2025The Abu Dhabi Stem Cells Centre ADSCC has achieved a major milestone in stem cell research by successfully developing clinicalgrade induced pluripotent stem cells iPSCs for the first time in the Middle East
Innovent Announces Approval of DOVBLERON® for Non-Small Cell Lung Cancer Treatment
Friday, January 03, 2025Innovent Biologics announced the approval of a second New Drug Application NDA for DOVBLERON taletrectinib adipate capsule by Chinas National Medical Products Administration NMPA
GSK’s Nucala Approved for Treating Chronic Rhinosinusitis with Nasal Polyps
Friday, January 03, 2025GSK has announced that Nucala mepolizumab a monoclonal antibody targeting interleukin IL has received approval from Chinas National Medical Products Administration
HUTCHMED Submits New Drug Application (NDA) for ORPATHYS® (savolitinib) in Combination with TAGRISSO®
Thursday, January 02, 2025HUTCHMED has announced that the China National Medical Products Administration NMPA has accepted a New Drug Application NDA for the combination therapy of ORPATHYS savolitinib and TAGRISSO osimertinib
Halozyme Announces Approval of VYVDURA with ENHANZE® for CIDP Treatment
Tuesday, December 31, 2024Halozyme Therapeutics has announced that VYVDURA developed by argenx and featuring Halozymes ENHANZE drug delivery technology has received regulatory approval in Japan Chronic Inflammatory Demyelinating Polyneuropathy CIDP is a rare autoimmune disord...
IDEAYA Biosciences Licenses SHR-4849 from Hengrui Pharma for Global Development
Monday, December 30, 2024IDEAYA Biosciences has secured an exclusive licence for SHR a novel DLLtargeting TopoIpayload antibodydrug conjugate ADC The agreement with Jiangsu Hengrui Pharmaceuticals enables IDEAYA to develop and commercialise SHR globally excluding Greater Chi...
Jadeite Medicines Secures Orphan Drug Designation for Odevixibat to Treat Alagille Syndrome
Thursday, December 26, 2024Jadeite Medicines has announced that odevixibat has been granted Orphan Drug Designation by Japans Ministry of Health Labour and Welfare MHLW for the treatment of Alagille Syndrome ALGS
Keymed Biosciences Gains Approval for Stapokibart to Treat Chronic Rhinosinusitis
Tuesday, December 24, 2024Keymed Biosciences has received approval from Chinas National Medical Products Administration NMPA for a supplemental New Drug Application sNDA of Stapokibart Stapokibart is a domestically developed humanized monoclonal antibody It targets ILR effect...
SK Bioscience Enters into Partnership with Sanofi to Develop Pneumococcal Conjugate Vaccines
Monday, December 23, 2024SK bioscience has strengthened its partnership with Sanofi to codevelop nextgeneration pneumococcal conjugate vaccines PCVs for both paediatric and adult populations
